Viridian Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
22 Jan 24 | BuyUS$9,999,990 | Fairmount Funds Management LLC | Company | 476,190 | US$21.00 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Individual Insiders | 35,074 | 0.0493% |
Hedge Funds | 5,031,420 | 7.07% |
VC/PE Firms | 10,995,823 | 15.4% |
Institutions | 55,142,930 | 77.4% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 45.5%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
9,415,135 | US$148.9m | 23.5% | 0.01% | |||
5,031,420 | US$79.6m | 4.94% | 2.74% | |||
4,488,615 | US$71.0m | 65.7% | no data | |||
3,882,671 | US$61.4m | 53.5% | 2.51% | |||
3,812,630 | US$60.3m | 11.3% | no data | |||
3,657,099 | US$57.9m | 111% | 1.06% | |||
3,456,053 | US$54.7m | -35.2% | 1.32% | |||
3,234,279 | US$51.2m | 7.78% | no data | |||
2,692,414 | US$42.6m | 15.8% | 0.76% | |||
1,934,653 | US$30.6m | 0.55% | 2.04% | |||
1,845,813 | US$29.2m | 34.8% | 2.27% | |||
1,722,819 | US$27.3m | -16.4% | 0.01% | |||
1,678,207 | US$26.5m | 0% | 1.97% | |||
1,335,000 | US$21.1m | 0% | 3.41% | |||
1,329,988 | US$21.0m | 472% | 0.01% | |||
1,164,272 | US$18.4m | 17.1% | no data | |||
1,100,000 | US$17.4m | 0% | 0.01% | |||
1,095,441 | US$17.3m | 4.24% | 0.01% | |||
948,130 | US$15.0m | -22.8% | 1.88% | |||
889,198 | US$14.1m | -9.26% | 0.05% | |||
762,411 | US$12.1m | -14% | 0.01% | |||
736,595 | US$11.7m | 25.6% | 2.17% | |||
700,000 | US$11.1m | 16.7% | 1.2% | |||
692,925 | US$11.0m | 0% | 1.18% | |||
625,000 | US$9.9m | 108% | 3.11% |